NCT05781087

Brief Summary

Heart attacks caused by the complete blockage of a heart artery are treated by opening it with a stent. However, most people will also have 'non-culprit' narrowings found in their other arteries at this time. Although in general people do better if these non-culprit narrowings are also treated with stents if they look severe, this process has problems. This is because narrowings that look severe may be stable and not cause any trouble. For these people a stent is a wasted procedure and unnecessary risk. On the other hand, narrowings that are currently left alone because they appear mild, may progress and cause a heart attack. Participants who have had a heart attack will have a scan from inside the heart arteries during an angiogram (optical coherence tomography, OCT) and a magnetic resonance angiogram (MRA). If the investigators can show that it is possible to accurately predict which non-culprit narrowings are going to progress and which are going to stabilise, medical professionals may be able to better target their treatments after a heart attack.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
23mo left

Started Apr 2023

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress61%
Apr 2023Apr 2028

First Submitted

Initial submission to the registry

March 9, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 23, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

April 25, 2023

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2028

Expected
Last Updated

September 25, 2024

Status Verified

September 1, 2024

Enrollment Period

2.4 years

First QC Date

March 9, 2023

Last Update Submit

September 24, 2024

Conditions

Keywords

optical coherence tomographynon-culpritmagnetic resonance imagingcardiac magnetic resonanceSTEMImagnetic resonance angiographyOCT

Outcome Measures

Primary Outcomes (1)

  • Change in mean fibrous cap thickness measured by optical coherence tomography

    6 months

Secondary Outcomes (3)

  • Change in mean lipid arc measured by optical coherence tomography

    6 months

  • Presence of thin cap fibroatheroma measured by optical coherence tomography

    6 months

  • Change in measures of shear stress made by optical coherence tomography and magnetic resonance angiography

    0 and 6 months

Other Outcomes (2)

  • Non-culprit major adverse cardiac events

    6 months and 36 months

  • Change in vessel stenosis measured by optical coherence tomography and magnetic resonance angiography

    0, 6 and 36 months

Study Arms (1)

Standard of care

Patients after ST-elevation myocardial infarction with non-culprit coronary artery disease.

Diagnostic Test: Optical coherence tomography and pressure wire assessmentDiagnostic Test: Cardiac magnetic resonance angiogram

Interventions

Non-culprit coronary arteries

Also known as: OCT (Abbott), PressureWire X (Abbott)
Standard of care

1.5T

Also known as: Cardiac MRI
Standard of care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients after presentation with ST elevation myocardial infarction.

You may qualify if:

  • Successful primary percutaneous coronary intervention (PCI) within the previous week with no major complications at the index procedure
  • Bystander disease in a non-culprit vessel planned for clinically indicated staged angiography +/- PCI
  • Able to provide written informed consent.

You may not qualify if:

  • Cardiogenic shock requiring intubation, inotropes or a mechanical support device
  • Creatinine clearance \<30ml/min
  • Prior coronary artery bypass grafting
  • Life expectancy less than 3 years
  • Pregnancy.
  • Target lesion in the left main coronary artery
  • Severe calcification or tortuosity that would threaten safe placement of a pressure wire or OCT catheter
  • Chronic total occlusion of a major epicardial vessel.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

St Thomas' Hospital

London, SE1 7EH, United Kingdom

RECRUITING

King's College Hospital

London, SE5 9RS, United Kingdom

RECRUITING

MeSH Terms

Conditions

Coronary Artery DiseaseST Elevation Myocardial InfarctionMyocardial Ischemia

Interventions

Tomography, Optical Coherence

Condition Hierarchy (Ancestors)

Coronary DiseaseHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesMyocardial InfarctionInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Intervention Hierarchy (Ancestors)

Tomography, OpticalOptical ImagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisTomographyInvestigative Techniques

Study Officials

  • Divaka Perera, MD

    King's College London

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Matthew Li Kam Wa, MBBS

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 9, 2023

First Posted

March 23, 2023

Study Start

April 25, 2023

Primary Completion

October 1, 2025

Study Completion (Estimated)

April 1, 2028

Last Updated

September 25, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations